NCT04189705View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis

PHASE3CompletedINTERVENTIONAL
Enrollment

392

Participants

Timeline

Start Date

December 30, 2019

Primary Completion Date

April 23, 2020

Study Completion Date

April 23, 2020

Conditions
Acute GastritisChronic Gastritis
Interventions
DRUG

MCT-SR

Rebamipide 150mg

DRUG

Mucosta Tab.

Rebamipide 100mg

Trial Locations (1)

Unknown

Chung-Ang University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY